Biophotonic compositions and methods for providing biophotonic treatment

a biophotonic and composition technology, applied in the field of biophotonic compositions and methods for providing biophotonic treatment, can solve the problems of undesired side effects, low therapeutic efficacy of existing regimens, etc., and achieve the effect of reducing the duration of systemic treatment tim

Inactive Publication Date: 2013-10-24
KLOX TECH
View PDF6 Cites 25 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0036]The disclosed methods for treating acne or wounds may further include, for example, administering a systemic or topical drug before, during or after the biophotonic treatment. The drug may be an antibiotic, a hormone...

Problems solved by technology

Such regimens, however, are often associated with undesired side-effects, including systemic or localized toxicity due to the direct contact of the photosensitive agents wit...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biophotonic compositions and methods for providing biophotonic treatment
  • Biophotonic compositions and methods for providing biophotonic treatment
  • Biophotonic compositions and methods for providing biophotonic treatment

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0237]The photodynamic properties of (i) Fluorescein sodium salt at about 0.09 mg / mL, (ii) Eosin Y at about 0.305 mg / mL, and (iii) a mixture of Fluorescein sodium salt at about 0.09 mg / mL and Eosin Y at about 0.305 mg / mL in a gel according to an embodiment of the present disclosure (comprising about 12% carbamide peroxide), were evaluated. A flexstation 384 II spectrometer was used with the following parameters: mode fluorescence, excitation 460 nm, emission spectra 465-750 nm. The absorption and emission spectra are shown in FIGS. 6a and 6b which indicate an energy transfer between the chromophores in the combination.

example 2

[0238]The photodynamic properties of (i) Fluorescein sodium salt at 0.18 mg / mL final concentration, (ii) Eosin Y at about 0.305 mg / mL, and (iii) a mixture of Fluorescein sodium salt at about 0.18 mg / mL and Eosin Y at about 0.305 mg / mL in an aqueous solution were evaluated. A flexstation 384 II spectrometer was used with the following parameters: mode fluorescence, excitation 460 nm, emission spectra 465-750 nm. The absorption and emission spectra are shown in FIGS. 7a and 7b which indicate an energy transfer between the chromophores in the combination.

example 3

[0239]The photodynamic properties of (i) Rose Bengal at about 0.085 mg / mL, (ii)

[0240]Fluorescein sodium salt at about 0.44 mg / mL final concentration, (ii) Eosin Y at about 0.305 mg / mL, and (iii) a mixture of (i), (ii) and (iii) in a gel comprising about 12% carbamide peroxide (Set A), according to an embodiment of the invention, were evaluated. A flexstation 384 II spectrometer was used with the following parameters: mode fluorescence, excitation 460 nm, emission spectra 465-750 nm. The absorbance and emission spectra are shown in FIGS. 8a and 8b which indicate an energy transfer between the chromophores in the chromophore combination.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Hygroscopicityaaaaaaaaaa
Login to view more

Abstract

The present disclosure provides biophotonic topical compositions and methods useful in phototherapy. In particular, the biophotonic topical compositions of the present disclosure are substantially resistant to leaching such that very low amounts of chromophore(s) present in the biophotonic composition leach out of the composition. The biophotonic compositions and the methods of the present disclosure are useful for promoting wound healing and skin rejuvenation, as well as treating acne and various skin disorders.

Description

CROSS-REFERENCE TO RELATED APPLICATION[0001]This application claims the benefit of U.S. Provisional Application Nos. 61 / 636,480, filed Apr. 20, 2012; 61 / 701,502, filed Sep. 14, 2012; 61 / 636,574 filed on Apr. 20, 2012; 61 / 701,510, filed on Sep. 14, 2012; 61 / 636,577, filed on Apr. 20, 2012; 61 / 701,513, filed on Sep. 14, 2012; and 61 / 766,611, filed on Feb. 19, 2013; which applications are hereby incorporated by reference in their entireties.BACKGROUND OF THE DISCLOSURE[0002]Phototherapy has recently been recognized as having wide range of applications in both the medical, cosmetic and dental fields for use in surgeries, therapies and examinations. For example, phototherapy has been developed to treat cancers and tumors with lessened invasiveness. Phototherapy has also been used to disinfect target sites as an antimicrobial treatment. Phototherapy has also been found to promote wound healing.[0003]Photodynamic therapy is a type of phototherapy which involves a step of systemic administr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K41/00A61N5/06
CPCA61K41/00A61N5/06A61K8/042A61K8/22A61K8/498A61K8/8147A61K41/0042A61K41/0057A61N5/0616A61N5/062A61Q19/00A61Q19/02A61Q19/08A61K2800/262A61K2800/434A61K2800/5922A61K2800/81A61N2005/0645A61N2005/0647A61N2005/0662A61N2005/0663A61P1/02A61P17/00A61P17/02A61P17/10A61P29/00A61P43/00A61K9/06A61K9/48A61K31/352C09K11/02C09K11/06A61K9/0014
Inventor PIERGALLINI, REMIGIOLOUPIS, NIKOLAOSRASTOGI, SHIPRA
Owner KLOX TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products